题名 | The Quality of Randomized Controlled Trials on DanShen in the Treatment of Ischemic Vascular Disease |
作者 | |
发表日期 | 2009-05 |
发表期刊 | JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
其他关键词 | TRADITIONAL CHINESE MEDICINE ; METHODOLOGICAL QUALITY ; CONSORT STATEMENT ; IMPROVE |
摘要 | Background and objectives: Many randomized controlled trials (RCTs) were conducted to evaluate the efficacy of DanShen (Salvia miltiorrhizae, an herbal medicine) on ischemic vascular diseases (IVD). However, there has been no systematic evaluation of the quality of DanShen RCTs so far. The aims of this study were (1) to assess the quality of DanShen RCTs on IVD published in mainland China from 1998 to 2007 and (2) to explore the factors correlating with the quality. Design: A number of Chinese databases were searched, and most of DanShen RCTs on IVD were collected. According to CONSORT for TCM (Consolidated Standards for Reporting of Trials for Traditional Chinese Medicine) and the Jadad scale, the quality assessment and data abstraction were performed independently by two reviewers. One-way analysis of variance and Pearson correlation analysis were applied to explore the association between basic characteristic and the quality of the RCTs. Results: One hundred and fifty (150) DanShen RCTs were identified finally. The mean (standard deviation) score of 150 DanShen RCTs assessed by CONSORT for TCM was 23.87 (3.68), and 1.94 (0.82) by the Jadad scale, respectively. Only 6.7% (10/150) of RCTs were identified with high quality (Jadad score >= 4). Authors' affiliation, publication journal, sample size, and follow-up time were correlated with the quality of DanShen RCTs. Conclusions: The quality of DanShen RCTs in mainland China has not been improved significantly over recent years, and the overall quality of DanShen RCTs is still poor. |
出版者 | MARY ANN LIEBERT, INC |
出版地 | NEW ROCHELLE |
ISSN | 1075-5535 |
EISSN | 1557-7708 |
卷号 | 15期号:5页码:557-565 |
DOI | 10.1089/acm.2008.0436 |
页数 | 9 |
WOS类目 | Integrative & Complementary Medicine |
WOS研究方向 | Integrative & Complementary Medicine |
WOS记录号 | WOS:000266220400018 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
URL | 查看原文 |
PubMed ID | 19425821 |
SCOPUSEID | 2-s2.0-67149146569 |
通讯作者地址 | [Zhang, Huaiqing]Department of Cardiovascular Diseases,First Affiliated Hospital,Wenzhou Medical College,No. 2 Fuxue Lane,China |
Scopus学科分类 | Complementary and Alternative Medicine |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/17246 |
专题 | 附属第一医院_心血管内科 第一临床医学院(信息与工程学院)、附属第一医院_内科学_感染内科 |
通讯作者 | Zhang, Huaiqing |
作者单位 | 1.Department of Cardiovascular Diseases,First Affiliated Hospital,Wenzhou Medical College,China; 2.School of Public Health,Peking University,China; 3.Department of Infection and Liver Diseases,First Affiliated Hospital,Wenzhou Medical College,China; 4.Department of Cardiovascular Diseases,First Affiliated Hospital,Wenzhou Medical College,No. 2 Fuxue Lane,China |
第一作者单位 | 附属第一医院 |
通讯作者单位 | 附属第一医院 |
第一作者的第一单位 | 附属第一医院 |
推荐引用方式 GB/T 7714 | Yu, Shicheng,Zhong, Baoliang,Zheng, Minghua,et al. The Quality of Randomized Controlled Trials on DanShen in the Treatment of Ischemic Vascular Disease[J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE,2009,15(5):557-565. |
APA | Yu, Shicheng, Zhong, Baoliang, Zheng, Minghua, Xiao, Fangyi, Dong, Zhibing, & Zhang, Huaiqing. (2009). The Quality of Randomized Controlled Trials on DanShen in the Treatment of Ischemic Vascular Disease. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 15(5), 557-565. |
MLA | Yu, Shicheng,et al."The Quality of Randomized Controlled Trials on DanShen in the Treatment of Ischemic Vascular Disease".JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE 15.5(2009):557-565. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论